Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant

Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant

US Patent 11351255 · Granted Jun 7, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MUC16 monoclonal antibody and uses thereof2023
Methods of increasing delivery of anti-cancer agents to targets2021
Methods of increasing delivery of anti-cancer agents to targets2021
Treatment of cancer with therapeutic monoclonal antibody specific for a tumor as2020
Treatment of cancer with therapeutic monoclonal antibody specific for a tumor as2020
Tumor antigen specific antibodies and TLR3 stimulation to enhance the performanc2019
Tumor antigen specific antibodies and TLR3 stimulation to enhance the performanc2019
Methods for improving the bioactivity of therapeutic IgE antibodies for the trea2015
Polymeric nanoparticles for photosensitizers2014
IgE antibodies for the treatment of cancer2014
Method and device for photodynamic therapy2013
Combination therapy for treating disease2011